496 related articles for article (PubMed ID: 31793418)
21. A Randomized, Double-Blind Study of the Effects of a Sustained Release Formulation of Sodium Nitrite (SR-nitrite) on Patients with Diabetic Neuropathy.
Soin A; Bock G; Giordano A; Patel C; Drachman D
Pain Physician; 2018 Mar; 21(2):179-190. PubMed ID: 29565948
[TBL] [Abstract][Full Text] [Related]
22. Short-Term Efficacy of CBD-Enriched Hemp Oil in Girls with Dysautonomic Syndrome after Human Papillomavirus Vaccination.
Palmieri B; Laurino C; Vadalà M
Isr Med Assoc J; 2017 Feb; 19(2):79-84. PubMed ID: 28457055
[TBL] [Abstract][Full Text] [Related]
23. Amitriptyline for neuropathic pain and fibromyalgia in adults.
Moore RA; Derry S; Aldington D; Cole P; Wiffen PJ
Cochrane Database Syst Rev; 2012 Dec; 12():CD008242. PubMed ID: 23235657
[TBL] [Abstract][Full Text] [Related]
24. Cannabidiol (CBD) as a treatment of acute and chronic back pain: A case series and literature review.
Eskander JP; Spall J; Spall A; Shah RV; Kaye AD
J Opioid Manag; 2020; 16(3):215-218. PubMed ID: 32421842
[TBL] [Abstract][Full Text] [Related]
25. Transdermal Buprenorphine Relieves Neuropathic Pain: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial in Diabetic Peripheral Neuropathic Pain.
Simpson RW; Wlodarczyk JH
Diabetes Care; 2016 Sep; 39(9):1493-500. PubMed ID: 27311495
[TBL] [Abstract][Full Text] [Related]
26. Oxycodone for neuropathic pain and fibromyalgia in adults.
Gaskell H; Moore RA; Derry S; Stannard C
Cochrane Database Syst Rev; 2014 Jun; (6):CD010692. PubMed ID: 24956205
[TBL] [Abstract][Full Text] [Related]
27. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD).
Good P; Haywood A; Gogna G; Martin J; Yates P; Greer R; Hardy J
BMC Palliat Care; 2019 Dec; 18(1):110. PubMed ID: 31810437
[TBL] [Abstract][Full Text] [Related]
28. The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial.
Boggs DL; Surti T; Gupta A; Gupta S; Niciu M; Pittman B; Schnakenberg Martin AM; Thurnauer H; Davies A; D'Souza DC; Ranganathan M
Psychopharmacology (Berl); 2018 Jul; 235(7):1923-1932. PubMed ID: 29619533
[TBL] [Abstract][Full Text] [Related]
29. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract.
Nadulski T; Pragst F; Weinberg G; Roser P; Schnelle M; Fronk EM; Stadelmann AM
Ther Drug Monit; 2005 Dec; 27(6):799-810. PubMed ID: 16306858
[TBL] [Abstract][Full Text] [Related]
30. Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial.
Schoedel KA; Szeto I; Setnik B; Sellers EM; Levy-Cooperman N; Mills C; Etges T; Sommerville K
Epilepsy Behav; 2018 Nov; 88():162-171. PubMed ID: 30286443
[TBL] [Abstract][Full Text] [Related]
31. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial.
Lesser H; Sharma U; LaMoreaux L; Poole RM
Neurology; 2004 Dec; 63(11):2104-10. PubMed ID: 15596757
[TBL] [Abstract][Full Text] [Related]
32. Nutmeg extracts for painful diabetic neuropathy: a randomized, double-blind, controlled study.
Motilal S; Maharaj RG
J Altern Complement Med; 2013 Apr; 19(4):347-52. PubMed ID: 23098698
[TBL] [Abstract][Full Text] [Related]
33. Protocol for a pragmatic trial of Cannabidiol (CBD) to improve chronic pain symptoms among United States Veterans.
Bergmans RS; Wegryn-Jones R; Klida C; Kurtz V; Thomas L; Williams DA; Clauw DJ; Kidwell KM; Bohnert ASB; Boehnke KF
BMC Complement Med Ther; 2024 Jun; 24(1):250. PubMed ID: 38951902
[TBL] [Abstract][Full Text] [Related]
34. A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms.
Wade DT; Robson P; House H; Makela P; Aram J
Clin Rehabil; 2003 Feb; 17(1):21-9. PubMed ID: 12617376
[TBL] [Abstract][Full Text] [Related]
35. [Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies].
Petzke F; Enax-Krumova EK; Häuser W
Schmerz; 2016 Feb; 30(1):62-88. PubMed ID: 26830780
[TBL] [Abstract][Full Text] [Related]
36. An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics.
Johnson JR; Lossignol D; Burnell-Nugent M; Fallon MT
J Pain Symptom Manage; 2013 Aug; 46(2):207-18. PubMed ID: 23141881
[TBL] [Abstract][Full Text] [Related]
37. A pilot study of the beneficial effects of amantadine in the treatment of painful diabetic peripheral neuropathy.
Amin P; Sturrock ND
Diabet Med; 2003 Feb; 20(2):114-8. PubMed ID: 12581262
[TBL] [Abstract][Full Text] [Related]
38. Cannabidiol prevents chemotherapy-induced neuropathic pain by modulating spinal TLR4 via endocannabinoid system activation.
Dos Santos R; Veras F; Netto G; Elisei L; Sorgi C; Faccioli L; Galdino G
J Pharm Pharmacol; 2023 Apr; 75(5):655-665. PubMed ID: 36946366
[TBL] [Abstract][Full Text] [Related]
39. Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 'N of 1' studies.
Notcutt W; Price M; Miller R; Newport S; Phillips C; Simmons S; Sansom C
Anaesthesia; 2004 May; 59(5):440-52. PubMed ID: 15096238
[TBL] [Abstract][Full Text] [Related]
40. Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.
Drugs R D; 2003; 4(5):306-9. PubMed ID: 12952500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
